Pharvaris
Umar Katbeh, MA, PhD, is a seasoned professional in the pharmaceutical industry, currently serving as Senior Director and Global Medical Affairs Lead at Pharvaris since August 2023. Prior experience includes roles at Alexion Pharmaceuticals, Inc. from May 2017 to August 2023, where Umar held titles such as Director of Global Medical Communications and Medical Lead for the Middle East and North Africa. In these positions, expertise was applied to the development and execution of medical affairs plans tailored to regional business needs and global strategies, alongside fostering collaborations with key opinion leaders for scientific exchange. Umar's academic background includes a Bachelor of Arts in Natural Sciences from the University of Cambridge, a Doctor of Philosophy in Clinical Medicine from Imperial College London, and a Master of Arts in Natural Sciences from the University of Cambridge.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.